Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Arthritis, Juvenile D001171 8 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Synovitis D013585 15 associated lipids
Arthralgia D018771 8 associated lipids
Hemophilia A D006467 10 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Gilbert Disease D005878 2 associated lipids
Hydrarthrosis D006833 1 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
Spisani S et al. 3-(Carboxyalkylthio) rifamycin S and SV derivatives inhibit human neutrophil functions. 1998 Inflammation pmid:9793793
Erel F et al. Severe anaphylaxis from rifamycin SV. 1998 Ann. Allergy Asthma Immunol. pmid:9759804
Crance JM et al. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. 1997 Sep-Oct Res. Virol. pmid:9403935
González CI et al. Reverse transcriptase-like activity in Trypanosoma cruzi. 1997 Acta Trop. pmid:9088425
Chiao JS et al. Rifamycin SV and related ansamycins. 1995 Biotechnology pmid:8688635
Abu-Shady MR et al. Studies of rifamycin production by Amycolatopsis mediterranei cells immobilized on glass wool. 1995 J. Basic Microbiol. pmid:8568638
Ward TJ et al. Enantiomeric resolution using the macrocyclic antibiotics rifamycin B and rifamycin SV as chiral selectors for capillary electrophoresis. 1995 J Chromatogr A pmid:8520671
Marchesoni A et al. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. 1993 Scand. J. Rheumatol. pmid:8356413
Sáez GT et al. The role of glutathione in protection against DNA damage induced by rifamycin SV and copper(II) ions. 1993 Free Radic. Res. Commun. pmid:8225041
Caruso I et al. Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumatoid arthritis. 1993 Sep-Oct J. Int. Med. Res. pmid:8112482
Persico M et al. The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis. 1994 Eur. J. Clin. Invest. pmid:8033955
Fardel O et al. Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. 1995 Biochem. Pharmacol. pmid:7763306
Muñiz P et al. The role of 8-hydroxy-2'-deoxyguanosine in rifamycin-induced DNA damage. 1995 Free Radic. Biol. Med. pmid:7750799
Kukiełka E and Cederbaum AI Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV. 1995 Biochem. J. pmid:7733870
Cardot E et al. Anaphylactic reaction to local administration of rifamycin SV. 1995 J. Allergy Clin. Immunol. pmid:7529781
Okolicsanyi L et al. Influence of rifamycin SV on bile acid metabolism in rats. 1980 Naunyn Schmiedebergs Arch. Pharmacol. pmid:7422017
Bellomo P et al. Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins. 1981 J. Med. Chem. pmid:7310806
Xiao-Chang F and Naganawa H 1H NMR analysis of R-75-1 substance. 1981 Jpn J Antibiot pmid:7289042
Spisani S et al. [Effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis]. 1981 Boll. Soc. Ital. Biol. Sper. pmid:7236419
Ghisalba O et al. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis. 1982 J. Antibiot. pmid:7200089
Fernandes D and Giacinti F [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. 1982 Jan-Jun G Batteriol Virol Immunol pmid:7187341
Kono Y Aerobic oxidation of rifamycin SV to rifamycin S catalyzed by horseradish peroxidase. 1982 J. Biochem. pmid:7096316
Spisani S et al. The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. 1982 Scand. J. Rheumatol. pmid:7089503
Cottafava F et al. [Rheumatoid synovitis of the knee, treated successfully with intra-articular rifamycin SV]. 1982 Minerva Pediatr. pmid:7070359
Quinn FR The quantitative structure-activity relationship of rifamycin B amide and hydrazide toxicity in mice. 1982 Farmaco Sci pmid:7056391
Caruso I et al. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. 1982 Ann. Rheum. Dis. pmid:7046652
Karaivanov L et al. [Attempt at eliminating the multiple drug resistance of E. coli in pigs with enteritis using Rimactin]. 1980 Vet Med Nauki pmid:7015689
Bruni L et al. Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. 1980 J. Int. Med. Res. pmid:6987112
Arora SK Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV. 1983 Mol. Pharmacol. pmid:6865897
Nikiforov VG et al. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli. 1982 FEBS Lett. pmid:6761147
Gentile S et al. Plasma clearance of nicotinic acid and rifamycin-SV, and their interaction in Gilbert's syndrome: application of a compartmental model. 1984 Hepatogastroenterology pmid:6724499
Dekio S and Jidoi J Mechanism of coagulase production in Staphylococcus aureus Smith. 1983 Zentralbl Bakteriol Mikrobiol Hyg A pmid:6673416
Vogt E [Effects of rifamycin SV and a neomycin-bacitracin combination on the healing of microbial eczema]. 1983 Z. Hautkr. pmid:6649743
Craven N and Anderson JC Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. 1983 Am. J. Vet. Res. pmid:6553464
Brufani M et al. The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives. 1984 J. Antibiot. pmid:6526730
Deshko TN et al. [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. 1984 Bioorg. Khim. pmid:6388581
Bruni L et al. Herpes zoster treatments: results of a clinical trial relative to the use of rifamycin SV versus neuramide. 1984 J. Int. Med. Res. pmid:6381169
Freymuth F et al. [In vitro activity of rifamycin SV on herpes simplex and herpes varicella viruses]. 1983 May-Jun Therapie pmid:6310814
Păunescu E et al. [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. 1982 Apr-Jun Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol pmid:6294806
Kono Y and Sugiura Y Electron spin resonance studies on the oxidation of rifamycin SV catalyzed by metal ions. 1982 J. Biochem. pmid:6279586
Kono Y Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide. 1982 J. Biochem. pmid:6279585
Amagai T et al. The effect of ribavirin and rifamycin SV on age-dependent changes of the immune system during the adult life of SJL mice. 1982 Immunol. Lett. pmid:6210629
Revuz J et al. [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. 1983 Ann Dermatol Venereol pmid:6195953
Xiao-Chang F et al. Biochemical study of R-75-1, a new semi-synthetic rifamycin. 1981 J. Antibiot. pmid:6168632
Kradolfer F et al. Chemotherapeutic activity of new derivatives of rifamycin. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985258
Okolicsanyi L et al. [Effect of rifamycin SV on the metabolism of bile salts in the rat]. 1979 Jan-Dec G Ital Chemioter pmid:554815
Marchi E et al. [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV]. 1979 Jan-Dec G Ital Chemioter pmid:554811
Gentile S et al. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers]. 1979 Boll. Soc. Ital. Biol. Sper. pmid:552849
Nitti V The antituberculous activity of rifamycin SV. 1965 Helv Med Acta pmid:4958120
Maggi N et al. New derivatives of rifamycin SV. 1965 Antimicrob Agents Chemother (Bethesda) pmid:4956802